Trichostatin D
Latest Information Update: 16 Dec 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Developer Kirin Brewery; Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 23 Aug 2000 Preclinical development for Cancer in Japan (Unknown route)